Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoThe data were presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress ...
Novel vaccine concept generates immune responses that could produce multiple types of HIV...
Medical Xpress· 5 days agoUsing a combination of cutting-edge immunologic technologies, researchers have successfully...
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks· 5 days agoNovartis (NVS) reports phase III data that confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria.
Intellia ups the ante in HAE dosing battle, showcasing durability of one-and-done option
FierceBiotech· 3 days agoThe future of hereditary angiodema treatment seems to be coming down to how many shots it takes to...
...Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical...
Benzinga· 5 days ago-- Breadth of data across 7 presentations, including 4 oral, reflects continued leadership in advancing the understanding and treatment of</ ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 19 hours agoUNION therapeutics announces successful completion of the ADESOS Phase 2b study and presentation of data at the RAVE Conference 2024 ...
Did pandemic lockdowns stunt kids' immune systems long-term?
LiveScience· 6 days agoThe COVID-19 pandemic drastically reduced people's in-person interactions with others as events were...
Chinese cell therapy may treat asthma long term with a single jab: study
South China Morning Post· 3 days agoCytokines are signalling proteins that help control inflammation in the body, but too many cytokines...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoBlueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical Benefits of AYVAKIT®/AYVAKYT® (avapritinib ...
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 5 days agoThis included improvements in weekly urticaria activity score (UAS7), itch severity score (ISS7), ...